MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 69 filers reported holding MIRATI THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.11 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,656 | +11.6% | 7,499 | -7.4% | 0.00% | – |
| Q2 2023 | $292,653 | -63.5% | 8,100 | -62.4% | 0.00% | -100.0% |
| Q1 2023 | $801,043 | -66.3% | 21,545 | -36.6% | 0.00% | -85.7% |
| Q3 2022 | $2,375,000 | -28.1% | 34,000 | -30.9% | 0.01% | -30.0% |
| Q2 2022 | $3,303,000 | +331.8% | 49,200 | +429.0% | 0.01% | +400.0% |
| Q1 2022 | $765,000 | -53.9% | 9,300 | -17.7% | 0.00% | -60.0% |
| Q4 2021 | $1,658,000 | +44.2% | 11,300 | +73.8% | 0.01% | +25.0% |
| Q3 2021 | $1,150,000 | -10.0% | 6,500 | +11.7% | 0.00% | -20.0% |
| Q4 2020 | $1,278,000 | +91.0% | 5,817 | -33.1% | 0.01% | 0.0% |
| Q1 2020 | $669,000 | -69.6% | 8,700 | -49.0% | 0.01% | -68.8% |
| Q4 2019 | $2,198,000 | +239.7% | 17,057 | +105.5% | 0.02% | +166.7% |
| Q3 2019 | $647,000 | -91.4% | 8,300 | -88.6% | 0.01% | -90.8% |
| Q2 2019 | $7,509,000 | +303.3% | 72,900 | +187.0% | 0.06% | +364.3% |
| Q1 2019 | $1,862,000 | +220.5% | 25,400 | +85.4% | 0.01% | +180.0% |
| Q4 2018 | $581,000 | +91.7% | 13,700 | +122.6% | 0.01% | +150.0% |
| Q2 2018 | $303,000 | +1162.5% | 6,155 | +71.0% | 0.00% | – |
| Q3 2016 | $24,000 | – | 3,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |